Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N-n-propylnorapomorphine

Known as: N-propylnorapomorphine, n-propylapomorphine, 6-propylnorapomorphine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Dopaminergic signaling pathways have been extensively investigated using PET imaging, primarily with antagonist radioligands of D… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The actions on central dopamine (DA) mechanisms of raclopride, a new substituted benzamide, were studied by means of behavioural… Expand
  • figure 2
  • table 1
  • figure 3
  • figure 4
  • table 2
Is this relevant?
2003
2003
The binding of radioligand agonists to dopamine receptors in living brain can be informative about the abundance of receptors… Expand
Is this relevant?
2002
2002
According to the ternary complex model of G-protein linkage to receptors, agonists increase the affinity of the receptors for the… Expand
Is this relevant?
1997
1997
Changes in D2-like dopamine (DA) receptor binding in rat brain regions were compared by quantitative in vitro receptor… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1990
Highly Cited
1990
The design, synthesis, and pharmacological properties of a novel type of 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2… Expand
Is this relevant?
1990
1990
Cabergoline is a potent dopaminergic agent that interacts with agonists and antagonists of dopamine receptors in vitro. We… Expand
Is this relevant?
1989
1989
Summary(1) The influence of various dopamine (DA) receptor agonists and antagonists on the kinetic properties of the specific… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1989
1989
Injection of the dopamine (DA) agonist R-(-)-N-n-propylnorapomorphine (NPA; 5-40 micrograms) into anterior ventral striatal sites… Expand
Is this relevant?
1986
1986
We administered N-propylnorapomorphine, a potent aporphine-family dopamine (DA) agonist, to schizophrenic patients with active… Expand
Is this relevant?